Talimogene Laherparepvec
Amgen
['melanoma']
regarding neoadjuvant tx, 6 doses of t-vec prior to surgery met their primary endpoint of improving rfs in this phii trial. attention should be taken about statistical design of this study #esmo22 #melanoma 
Medical Oncologist. Melanoma and Skin Tumors. Early phase and phase III clinical trials. Hospital Clínic (Barcelona). Opinions are mine.